Goodrx Holdings, Inc. (GDRX) Stock Price & Analysis

Goodrx Holdings, Inc. (GDRX) fell 1.42% to USD 3.48 as of September 8, 2026 at 04:15 UTC, according to Nexqual real-time market data.

GDRX last closed at USD 3.48; the session ranged USD 3.45–3.52 on volume of 854,870 shares. Market capitalization is —, with a 52-week range of USD 1.77–5.81 (NMS). Source: Nexqual, September 8, 2026 at 04:15 UTC.

Key Statistics (as of September 8, 2026 at 04:15 UTC)

Technical Analysis (GDRX)

Nexqual's technical model rates GDRX "BUY" based on 4 bullish and 2 bearish signals across 128 daily candles, as of September 8, 2026 at 04:15 UTC.

From Goodrx Holdings, Inc.'s Latest SEC 10-K Filing (filed 2026-02-26)

Key Strengths & Strategy (as disclosed to the SEC)

• Our Technology The key elements of our technology include: • Proprietary Pricing Engine: Our price ingestion technology enables us to link with multiple sources spanning the healthcare industry.
• Our proprietary technology enables us to aggregate prescription pricing data points from sources spanning the healthcare industry.
• Our broad set of long-term relationships across the industry, combined with our proprietary platform, allows us to present highly competitive prices to consumers.
• Our proprietary technology enables us to combine prices from multiple PBMs and other industry sources and display it on a single consumer interface.

Partnerships

• In 2025, we partnered with select pharmacies to offer our brand medication savings solution, RxSmartSaver+ , to their consumers for a monthly or annual fee. • Condition-Specific Subscriptions: We first launched condition-specific subscriptions in 2025.
• In 2025, we continued to grow our consumer direct pricing and announced a collaboration with a pharmaceutical manufacturer to offer eligible patients nationwide two of the most in-demand GLP-1 medications at a significantly lower cash price through our platform.

Source: SEC EDGAR 10-K, official filing. Curated by Nexqual.

Peers & Related Stocks

Data source: Nexqual — real-time market data, technical indicators, analyst consensus, earnings, SEC EDGAR filings. Last updated: September 8, 2026 at 04:15 UTC. This page is informational and not investment advice.